Association Between Permanent Non-Valvular Atrial Fibrillation with Microalbuminuria and C-Reactive Protein
AbstractBackground: An understanding of atrial fibrillation (AF) mechanisms, as the most common cardiac arrhythmia, is essential for primary and secondary prevention. Some studies indicated an association between microalbuminuria and C-reactive protein (CRP) protein, with the incidence and prevalence of AF. This study aimed to investigate the relationship between permanent non-valvular AF with microalbuminuria and reactive protein C. Materials and Methods: In this case-control study, 40 permanent non-valvular AF patients and 40 non-AF patients (control group) were studied. Demographic data and measurements of albumin, urine creatinine, CRP, and microalbuminuria were recorded and compared between the two groups. Results: In patients with permanent non-valvular atrial fibrillation, CRP level (P<0.001) and microalbuminuria (P=0.012) were significantly higher than the control group. Also, in patients with permanent non-valvular AF, the CRP positive (P = 0.014) and microalbuminuria (P = 0.003) were significantly higher than controls. The results showed that elevated chance of permanent non-valvular AF with abnormal CRP was 4.25 (odds ratio [OR]= 4.25, 95% confidence interval [CI]: 1.18-1.28; P= 0.026), and with microalbuminuria was 6.54 (OR= 6.54, 95% CI: 1.65-25.89; P=0.007). Conclusion: An elevated CRP level and microalbuminuria were significantly associated with permanent non-valvular atrial fibrillation. A longitudinal study is necessary. [GMJ.2021;10:e2106]
Galea R, Cardillo MT, Caroli A, Marini MG, Sonnino C, Narducci ML, et al. Inflammation and C-reactive protein in atrial fibrillation: cause or effect? Texas Heart Institute Journal 2014; 41(5): 461-8.
Sarıkaya S, Şahin S, Akyol L, Börekçi E, Keser Y, Altunkaş F, Karaman K. Is there any relationship between RDW levels and atrial fibrillation in hypertensive patient?. African Health sciences 2014; 1(1): 267-274.
Kannie WB, Benjamin Ej. Status of epidemiology of atrial fibrillasion. Med Clin North Am 2008; 92(2): 17-40.
Vardas pE,Mavrakis HE. Atrial fibrillation:a symptom treated as a disease?Hellenic J Cardiol 2006; 47(2): 191-193.
Tamariz L, Hernandez F, Bush A, Palacio A, Hare JM. Association between serum uric acid and atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm 2014; 11(7): 1102-8.
Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998; 82(8): 2-9.
Dernellis J, Panaretou M. Effects of C-reactive protein and the third and fourth components of complement (C3 and C4) on incidence of atrial fibrillation. Am J Cardiol 2006; 97(2): 245-8.
Böhm M, Thoenes M, Neuberger HR, Gräber S, Reil JC, Bramlage P, et al. Atrial fibrillation and heart rate independently correlate to microalbuminuria in hypertensive patients. Eur Heart J 2009; 30(11): 1364-71.
Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS. Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 1999; 19(8): 1992-7.
Gurses KM, Yalcin MU, Kocyigit D, Evranos B, Ates AH, Yorgun H, et al. Red blood cell distribution width predicts outcome of cryoballoon-based atrial fibrillation ablation. J Interv Card Electrophysiol 2015;42(1):51-8.
McManus DD, Corteville DC, Shlipak MG, Whooley MA, Ix JH. Relation of kidney function and albuminuria with atrial fibrillation (from the Heart and Soul Study). Am J Cardiol 2009; 104(11): 1551-5.
Guo Y, Lip GY, Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol 2012; 60(2): 2263-70.
Patel P, Dokainish H, Tsai P, Lakkis N. Update on the Association of Inflammation and Atrial Fi brillation. Journal of cardiovascular electrophysiology 2010; 21(9): 1064-1070.
Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation.circulation 2001;104(3): 2886-91.
Asselbergs FW, van den Berg MP, Diercks GF, van Gilst WH, van Veldhuisen DJ. C-reactive protein and microalbuminuria are associated with atrial fibrillation. Int J Cardiol 2005; 98(1): 73-7.
Molnar AO, Eddeen AB, Ducharme R,Garg AX, et al.Association of Proteinuria andIncident Atrial Fibrillation in Patients With Intact and Reduced Kidney Function. J Am Heart Assoc.2017; 6(4): 5685.
Ehrlich JR, Hohnloser SH, Nattel S. Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence. Eur Heart J 2006; 27(1): 512-518.
McManus D, Corteville D, Shlipak MG, Whooley M, Masd J. Relation of Kidney Function and Albuminuria with Atrial Fibrillation (From the Heart and Soul Study). Am J Cardiol 2009; 104(11): 1551-1555.
Marott SC, Nordestgaard BG, Zacho J, Friberg J, Jensen GB, Tybjærg-Hansen A, et al. Does Elevated C-Reactive Protein Increase Atrial Fibrillation Risk?: A Mendelian Randomization of 47,000 Individuals From the General Population. Journal of the American College of Cardiology 2010; 56(10): 789-95.
Davies MJ, Pomerance A. Pathology of atrial fibrillation in man. Br Heart J 1972; 34(2): 520-5.
Frustaci A, Cristina C, Fulvio B, Emanuela M, Matteo A, Attilio M. Histological substrate of atrial biopsies in patients with lone atrial fibrillation Circulation 1997; 96(2): 1180-4.
Gür AK, Aykaç MC, Şişli M. The effects of serum CRP level on postoperative atrial fibrillation in patients who had coronary bypass surgery. East J Med 2018; 23(4): 284-288.
Naoyuki S, Naokazu H, Takashi H, Shigeru A, Takuya Y, Yukinori M, Kenkichi M. C-reactive Protein and Atrial Fibrillation. Jpn Heart J 2004; 45(3): 441-445.
Luft FC. Angiotensin, inflammation, hypertension, and cardiovascular disease. Curr Hypertens Rep 2001; 3(1): 61-67.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).